MAPT and Alzheimer disease: As it has been established, activated JNK is present in neurons and dystrophic neurites of both mice and brain AD models, which coincides with phosphorylation of protein insulin receptor substrate-1 (IRS-1) and tau, deposition of amyloid plaques and synapthophysin loss [301].